Dr. Sonali Chaudhury, MD
Claim this profileAnn & Robert H. Lurie Children's Hospital of Chicago
Studies Acute Lymphoblastic Leukemia
Studies Leukemia
11 reported clinical trials
20 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
CD19 positive
Stage II
Stage I
2Leukemia
CD19 positive
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Sonali Chaudhury, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
IST + BMT
for Aplastic Anemia
Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a matched sibling (brother or sister), or family donor is a bone marrow transplant. Patients without a matched family donor normally are treated with immune suppressive therapy (IST). Match unrelated donor (URD) bone marrow transplant (BMT) is used as a secondary treatment in patients who did not get better with IST, had their disease come back, or a new worse disease replaced it (like leukemia). This trial will compare time from randomization to failure of treatment or death from any cause of IST versus URD BMT when used as initial therapy to treat SAA. The trial will also assess whether health-related quality of life and early markers of fertility differ between those randomized to URD BMT or IST, as well as assess the presence of marrow failure-related genes and presence of gene mutations associated with MDS or leukemia and the change in gene signatures after treatment in both study arms. This study treatment does not include any investigational drugs. The medicines and procedures in this study are standard for treatment of SAA.
Recruiting2 awards Phase 3
More about Sonali Chaudhury, MD
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Sonali Chaudhury, MD has experience with
- Fludarabine
- Tabelecleucel
- Tisagenlecleucel
- Methotrexate
- Rabbit Anti-Thymocyte Globulin (ATG)
- Horse Anti-Thymocyte Globulin (ATG)
Breakdown of trials Sonali Chaudhury, MD has run
Acute Lymphoblastic Leukemia
Leukemia
Lymphoblastic Leukemia-Lymphoma
Aplastic Anemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sonali Chaudhury, MD specialize in?
Sonali Chaudhury, MD focuses on Acute Lymphoblastic Leukemia and Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are Stage II.
Is Sonali Chaudhury, MD currently recruiting for clinical trials?
Yes, Sonali Chaudhury, MD is currently recruiting for 7 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Sonali Chaudhury, MD has studied deeply?
Yes, Sonali Chaudhury, MD has studied treatments such as Fludarabine, Tabelecleucel, Tisagenlecleucel.
What is the best way to schedule an appointment with Sonali Chaudhury, MD?
Apply for one of the trials that Sonali Chaudhury, MD is conducting.
What is the office address of Sonali Chaudhury, MD?
The office of Sonali Chaudhury, MD is located at: Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois 60611 United States. This is the address for their practice at the Ann & Robert H. Lurie Children's Hospital of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.